Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Emberson

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|August 10, 2014
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsJonathan Emberson, Kennedy R Lees, Patrick Lyden, et al.
The Lancet. Neurology|June 13, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysisWilliam N Whiteley, Jonathan Emberson, Kennedy R Lees, et al.
Eclinicalmedicine|March 26, 2021
Alcohol consumption and cause-specific mortality in Cuba: prospective study of 120 623 adultsNurys B Armas Rojas, Ben Lacey, Daniel Martin Simadibrata, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 25, 2017
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trialsWerner Hacke, Patrick Lyden, Jonathan Emberson, et al.
Lancet (London, England)|September 1, 2022
Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trialsAlex Pitcher, Enti Spata, Jonathan Emberson, et al.
Science Advances|November 16, 2022
Human genetics uncovers <i>MAP3K15</i> as an obesity-independent therapeutic target for diabetesAbhishek Nag, Ryan S Dhindsa, Jonathan Mitchell, et al.
Journal of the American Society of Nephrology : JASN|December 12, 2023
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKDKaitlin J Mayne, Natalie Staplin, David F Keane, et al.
BMC Public Health|May 27, 2021
Body-mass index, blood pressure, diabetes and cardiovascular mortality in Cuba: prospective study of 146,556 participantsNurys B Armas Rojas, Ben Lacey, Monica Soni, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Nature Communications|February 19, 2025
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|August 10, 2014
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsJonathan Emberson, Kennedy R Lees, Patrick Lyden, et al.
The Lancet. Neurology|June 13, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysisWilliam N Whiteley, Jonathan Emberson, Kennedy R Lees, et al.
Eclinicalmedicine|March 26, 2021
Alcohol consumption and cause-specific mortality in Cuba: prospective study of 120 623 adultsNurys B Armas Rojas, Ben Lacey, Daniel Martin Simadibrata, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 25, 2017
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trialsWerner Hacke, Patrick Lyden, Jonathan Emberson, et al.
Lancet (London, England)|September 1, 2022
Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trialsAlex Pitcher, Enti Spata, Jonathan Emberson, et al.
Science Advances|November 16, 2022
Human genetics uncovers <i>MAP3K15</i> as an obesity-independent therapeutic target for diabetesAbhishek Nag, Ryan S Dhindsa, Jonathan Mitchell, et al.
Journal of the American Society of Nephrology : JASN|December 12, 2023
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKDKaitlin J Mayne, Natalie Staplin, David F Keane, et al.
BMC Public Health|May 27, 2021
Body-mass index, blood pressure, diabetes and cardiovascular mortality in Cuba: prospective study of 146,556 participantsNurys B Armas Rojas, Ben Lacey, Monica Soni, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Nature Communications|February 19, 2025
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Pageof 11